These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18071316)

  • 1. Skp2 regulates the antiproliferative function of the tumor suppressor RASSF1A via ubiquitin-mediated degradation at the G1-S transition.
    Song MS; Song SJ; Kim SJ; Nakayama K; Nakayama KI; Lim DS
    Oncogene; 2008 May; 27(22):3176-85. PubMed ID: 18071316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
    Auld CA; Fernandes KM; Morrison RF
    J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination.
    Hiramatsu Y; Kitagawa K; Suzuki T; Uchida C; Hattori T; Kikuchi H; Oda T; Hatakeyama S; Nakayama KI; Yamamoto T; Konno H; Kitagawa M
    Cancer Res; 2006 Sep; 66(17):8477-83. PubMed ID: 16951159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The F-box protein SKP2 binds to the phosphorylated threonine 380 in cyclin E and regulates ubiquitin-dependent degradation of cyclin E.
    Yeh KH; Kondo T; Zheng J; Tsvetkov LM; Blair J; Zhang H
    Biochem Biophys Res Commun; 2001 Mar; 281(4):884-90. PubMed ID: 11237742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
    Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS
    Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biphasic effect of p21Cip1 on smooth muscle cell proliferation: role of PI 3-kinase and Skp2-mediated degradation.
    Bond M; Sala-Newby GB; Wu YJ; Newby AC
    Cardiovasc Res; 2006 Jan; 69(1):198-206. PubMed ID: 16212951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid stabilizes p27Kip1 in EBV-immortalized lymphoblastoid B cell lines through enhanced proteasome-dependent degradation of the p45Skp2 and Cks1 proteins.
    Zancai P; Dal Col J; Piccinin S; Guidoboni M; Cariati R; Rizzo S; Boiocchi M; Maestro R; Dolcetti R
    Oncogene; 2005 Apr; 24(15):2483-94. PubMed ID: 15735731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P27 expression is regulated by separate signaling pathways, downstream of Ras, in each cell cycle phase.
    Sa G; Stacey DW
    Exp Cell Res; 2004 Nov; 300(2):427-39. PubMed ID: 15475007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel route for connexin 43 to inhibit cell proliferation: negative regulation of S-phase kinase-associated protein (Skp 2).
    Zhang YW; Nakayama K; Nakayama K; Morita I
    Cancer Res; 2003 Apr; 63(7):1623-30. PubMed ID: 12670914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of cell-cycle control: ligating the ligase.
    Lin DI; Diehl JA
    Trends Biochem Sci; 2004 Sep; 29(9):453-5. PubMed ID: 15337116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The atr protein kinase controls UV-dependent upregulation of p16INK4A through inhibition of Skp2-related polyubiquitination/degradation.
    Al-Khalaf HH; Hendrayani SF; Aboussekhra A
    Mol Cancer Res; 2011 Mar; 9(3):311-9. PubMed ID: 21270107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The F box protein S phase kinase-associated protein 2 regulates adipose mass and adipocyte number in vivo.
    Cooke PS; Holsberger DR; Cimafranca MA; Meling DD; Beals CM; Nakayama K; Nakayama KI; Kiyokawa H
    Obesity (Silver Spring); 2007 Jun; 15(6):1400-8. PubMed ID: 17557977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skp2 inversely correlates with p27 and tuberin in transformed cells.
    Rosner M; Hanneder M; Siegel N; Valli A; Fuchs C; Hengstschläger M
    Amino Acids; 2009 Jul; 37(2):257-62. PubMed ID: 18604603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for cytosolic p27(Kip1) ubiquitylation and degradation during adipocyte hyperplasia.
    Auld CA; Morrison RF
    Obesity (Silver Spring); 2006 Dec; 14(12):2136-44. PubMed ID: 17189539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitylation of RAG-2 by Skp2-SCF links destruction of the V(D)J recombinase to the cell cycle.
    Jiang H; Chang FC; Ross AE; Lee J; Nakayama K; Nakayama K; Desiderio S
    Mol Cell; 2005 Jun; 18(6):699-709. PubMed ID: 15949444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation.
    Huang H; Regan KM; Wang F; Wang D; Smith DI; van Deursen JM; Tindall DJ
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1649-54. PubMed ID: 15668399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
    Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
    Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipase C delta 1 regulates cell proliferation and cell-cycle progression from G1- to S-phase by control of cyclin E-CDK2 activity.
    Kaproth-Joslin KA; Li X; Reks SE; Kelley GG
    Biochem J; 2008 Nov; 415(3):439-48. PubMed ID: 18588506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells.
    Jiang F; Caraway NP; Li R; Katz RL
    Oncogene; 2005 May; 24(21):3409-18. PubMed ID: 15735730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer.
    Chiappetta G; De Marco C; Quintiero A; Califano D; Gherardi S; Malanga D; Scrima M; Montero-Conde C; Cito L; Monaco M; Motti ML; Pasquinelli R; Agosti V; Robledo M; Fusco A; Viglietto G
    Endocr Relat Cancer; 2007 Jun; 14(2):405-20. PubMed ID: 17639054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.